Tanomastat

DB06276ExperimentalSmall molecule

Investigated for use/treatment in pancreatic cancer, lung cancer, ovarian cancer, and osteoarthritis.

Chemical structure of Tanomastat
Primary indication
Investigated for use/treatment in pancreatic cancer, lung cancer, ovarian cancer, and osteoarthritis.Curator reviewed
Formula / weight
C23H19ClO3S · 410.91 g/mol (avg)
Code names
BAY 12-9566

Resolves to

Compound
UNIIAM1ZX94EXHCAS179545-77-8ChEMBLCHEMBL261932
Structure
InChIKeyJXAGDPXECXQWBC-LJQANCHMSA-NSMILESOC(=O)[C@@H](CSC1=CC=CC=C1)CC(=O)C1=CC=C(C=C1)C1=CC=C(Cl)C=C1
Targets
P08253MMP2

What you can answer from here — as of March 06, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Tanomastat, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In